Periodontal disease in HIV/AIDS

Area of Science:

• Oral medicine
• Infectious diseases
• Periodontology

Background:

• Adult AIDS death rates have decreased due to antiretroviral therapies and improved access.
• Global new human immunodeficiency virus (HIV) infections have slightly declined and stabilized.
• Significant numbers of existing and new HIV cases necessitate continued management of oral and periodontal conditions.

Purpose of the Study:

• To highlight the ongoing need for dental and healthcare practitioners to manage oral and periodontal conditions in HIV-infected populations.
• To emphasize the importance of developing accessible and affordable diagnostic and treatment strategies for periodontal diseases in HIV patients.
• To underscore the potential adverse effects of periodontal disease on HIV progression and antiretroviral therapy effectiveness.

Main Methods:

• Review of current literature on oral and periodontal conditions associated with HIV/AIDS.
• Analysis of the impact of antiretroviral therapy on the incidence and prevalence of these conditions.
• Discussion of the need for international collaboration in clinical trials for developing diagnostic and treatment approaches.

Main Results:

• Oral conditions like candidiasis, hairy leukoplakia, and Kaposi's sarcoma, though declining with treatment, still require attention.
• Conventional periodontal diseases remain prevalent in HIV-infected individuals.
• Systemic spread of oral microbiota and inflammation can negatively affect HIV progression and treatment efficacy.

Conclusions:

• Dental and healthcare providers must remain vigilant in diagnosing and treating oral and periodontal diseases in HIV-infected patients.
• Developing low-cost, accessible diagnostic and treatment methods for periodontal diseases is critical, especially in resource-limited settings.
• International, standardized clinical trials are necessary to assess and implement effective periodontal disease management strategies for HIV populations.